Parvoviral disease in childhood cancer: Clinical outcomes and impact on therapy at a tertiary cancer center in India

Ramanathan, Subramaniam; Narula, Gaurav; Prasad, Maya; Vora, Tushar; Chinnaswamy, Girish; Banavali, Shripad

doi:10.1002/pbc.27357

Cited by 4 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table (2) shows that IgM antibodies against human parvovirus B19 have been detected in 17 of the acute leukemia patients within the study group; these patients also have a high leukocytic count , a decreased hemoglobin level (5-7), a decreased platelet count (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25), and a high presence of blast cells (35-65); also, 67.7% of these leukemia patients have received blood or platelet transfusions during their treatment.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Sero-prevalence of human Parvovirus B19 Antibodies in Acute Leukaemia Patients of Suez Canal University Hospital

Hasanain

gomma

Attia

2023

Advances in Environmental and Life Sciences

View full text Add to dashboard Cite

Background: Human parvovirus B19 (PB19) is a small-sized DNA virus that infects human erythroid progenitor cells causing a sudden cessation of erythropoiesis. PB19 infection constitutes a high risk and may contribute to acute leukemia and worsen the physiological conditions.Objective: Screening acute leukemic patients in Suez Canal University Hospital for anti-human Parvovirus B19 antibodies.Methods: 75 blood samples from acute leukemia patients and 75 blood samples from healthy individuals recruited from Suez Canal University Hospital were subjected to screening for antihuman parvovirus B19 IgM and antihuman parvovirus B19 IgG antibodies by implementing the ELISA technique.Results: The prevalence of antihuman parvovirus B19 IgM and IgG antibodies in patients with acute leukemia was 22.7% and 98.7%, respectively. The prevalence of IgG antibodies against human parvovirus B19 within the control group was 14.7%. Conclusion:This study reported the presence of both types of anti-human parvovirus B19 IgM and IgG antibodies in acute leukemia patients in Suez Canal University hospital, which constitutes a high risk for acute leukemia patients and worsens their clinical blood parameters as well.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Rat parvovirus H-1(known as ParvOryx virus) is now subjected to many clinical trials to treat human glioblastoma multiforme [21], [22], [23], [24].…”

Section: Discussionmentioning

confidence: 99%